Patients with Cushing’s Syndrome have increased morbidity and mortality rates compared with the general population. Providing effective and timely management is therefore essential. Access the latest information on treatment, including guideline recommendations and managing comorbidities. Details of the ultimate expectations and goals are from treatment, the different comorbidities, current guidelines, transsphenoidal surgery, radiotherapy, bilateral adrenalectomy, pharmacological interventions and future treatments are all discussed.
Read key points from the Endocrine Society's comprehensive guideline for the treatment of Cushing's Syndrome, developed by experts from the UK, France and US, reaching consensus on best practice.
Learn about the most damaging and prevalent comorbidities for Cushing's Syndrome, such as dyslipidaemia, hypertension, cardiomyopathy, increased appetite and thrombophilia.
Treatment of Cushing's Syndrome takes the form of either pharmacological, surgical or radiological approach, each of which is appropriate for different patients, depending on pathophysiology.
Alternatively login via
Back to epgonline.org